Autoimmune hemolytic anemia epidemiology and demographics: Difference between revisions
Shyam Patel (talk | contribs) |
Shyam Patel (talk | contribs) No edit summary |
||
| Line 15: | Line 15: | ||
*The incidence of drug-induced hemolytic anemia is 1:1,000,000.<ref name="pmid26696800">{{cite journal| author=Packman CH| title=The Clinical Pictures of Autoimmune Hemolytic Anemia. | journal=Transfus Med Hemother | year= 2015 | volume= 42 | issue= 5 | pages= 317-24 | pmid=26696800 | doi=10.1159/000440656 | pmc=4678314 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26696800 }} </ref> | *The incidence of drug-induced hemolytic anemia is 1:1,000,000.<ref name="pmid26696800">{{cite journal| author=Packman CH| title=The Clinical Pictures of Autoimmune Hemolytic Anemia. | journal=Transfus Med Hemother | year= 2015 | volume= 42 | issue= 5 | pages= 317-24 | pmid=26696800 | doi=10.1159/000440656 | pmc=4678314 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26696800 }} </ref> | ||
*The prevalence of autoimmune hemolytic anemia is 17:100,000.<ref name="pmid25271314">{{cite journal| author=Zanella A, Barcellini W| title=Treatment of autoimmune hemolytic anemias. | journal=Haematologica | year= 2014 | volume= 99 | issue= 10 | pages= 1547-54 | pmid=25271314 | doi=10.3324/haematol.2014.114561 | pmc=4181250 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25271314 }} </ref> | *The prevalence of autoimmune hemolytic anemia is 17:100,000.<ref name="pmid25271314">{{cite journal| author=Zanella A, Barcellini W| title=Treatment of autoimmune hemolytic anemias. | journal=Haematologica | year= 2014 | volume= 99 | issue= 10 | pages= 1547-54 | pmid=25271314 | doi=10.3324/haematol.2014.114561 | pmc=4181250 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25271314 }} </ref> | ||
*Autoimmune hemolytic anemia affects men and women equally. | |||
*Autoimmune hemolytic anemia affects all racial backgrounds equally. | |||
==References== | ==References== | ||
Revision as of 19:14, 12 April 2018
|
Autoimmune hemolytic anemia Microchapters |
|
Differentiating Autoimmune hemolytic anemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Autoimmune hemolytic anemia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Autoimmune hemolytic anemia epidemiology and demographics |
|
FDA on Autoimmune hemolytic anemia epidemiology and demographics |
|
CDC on Autoimmune hemolytic anemia epidemiology and demographics |
|
Autoimmune hemolytic anemia epidemiology and demographics in the news |
|
Blogs on Autoimmune hemolytic anemia epidemiology and demographics |
|
Directions to Hospitals Treating Autoimmune hemolytic anemia |
|
Risk calculators and risk factors for Autoimmune hemolytic anemia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Assosciate Editor(s)-In-Chief: Prashanth Saddala M.B.B.S; Shyam Patel [2]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Overall, the incidence and prevalence of autoimmune hemolytic anemia is low. This condition affects a very small proportion of the population. Autoimmune hemolytic anemia affects men and women equally. There is no racial predilection for autoimmune hemolytic anemia.
Epidemiology and Demographics
- The incidence of autoimmune hemolytic anemia overall is estimated to be between 0.8:100,000 and 3:100,000 per year.[1].[2][3]
- The incidence of autoimmune hemolytic anemia in children is 0.2:100,000.[3] The incidence of autoimmune hemolytic anemia is higher in adults that in children.[2]
- The incidence of warm autoimmune hemolytic anemia is estimated to be between 1.25:100,000 and 1.33:100,000.[4]
- The incidence of drug-induced hemolytic anemia is 1:1,000,000.[4]
- The prevalence of autoimmune hemolytic anemia is 17:100,000.[3]
- Autoimmune hemolytic anemia affects men and women equally.
- Autoimmune hemolytic anemia affects all racial backgrounds equally.
References
- ↑ Böttiger LE, Westerholm B (1973). "Acquired haemolytic anaemia. I. Incidence and aetiology". Acta Med Scand. 193 (3): 223–6. PMID 4739592. Unknown parameter
|month=ignored (help) - ↑ 2.0 2.1 Berentsen S (2015). "Role of Complement in Autoimmune Hemolytic Anemia". Transfus Med Hemother. 42 (5): 303–10. doi:10.1159/000438964. PMC 4678321. PMID 26696798.
- ↑ 3.0 3.1 3.2 Zanella A, Barcellini W (2014). "Treatment of autoimmune hemolytic anemias". Haematologica. 99 (10): 1547–54. doi:10.3324/haematol.2014.114561. PMC 4181250. PMID 25271314.
- ↑ 4.0 4.1 Packman CH (2015). "The Clinical Pictures of Autoimmune Hemolytic Anemia". Transfus Med Hemother. 42 (5): 317–24. doi:10.1159/000440656. PMC 4678314. PMID 26696800.